All Updates

All Updates

icon
Filter
Funding
Altratech raises EUR 10.5 million in EIC Accelerator Programme funding
Precision Medicine
Oct 7, 2024
Last week:
Product updates
Eclipse launches Ethereum-Solana L2 network mainnet
Web3 Ecosystem
Nov 9, 2024
Funding
Oriole Networks raises USD 22 million in Series A funding to expand team and engage with suppliers
Machine Learning Infrastructure
Nov 9, 2024
Funding
Oriole Networks raises USD 22 million in Series A funding to expand team and engage with suppliers
Generative AI Infrastructure
Nov 9, 2024
Funding
GMI Cloud raises USD 82 million in Series A funding to expand AI infrastructure
Machine Learning Infrastructure
Nov 9, 2024
Funding
GMI Cloud raises USD 82 million in Series A funding to expand AI infrastructure
Generative AI Infrastructure
Nov 9, 2024
Funding
UnifyApps raises USD 20 million in Series A funding to expand AI platform
Workflow Automation Platforms
Nov 9, 2024
Regulation/policy
Federal court dismisses news outlets' copyright case against OpenAI
Generative AI Applications
Nov 8, 2024
Partnerships
Aptamer Group extends partnership with genetic medicines customer to provide targeted genetic medicine delivery vehicles
Precision Medicine
Nov 8, 2024
Funding
Upwind raises USD 100 million in Series B funding for global expansion and R&D
Next-gen Cybersecurity
Nov 8, 2024
Product updates
EHang completes debut passenger flights of EH216-S eVTOL in Thailand
Passenger eVTOL Aircraft
Nov 8, 2024
Precision Medicine

Precision Medicine

Oct 7, 2024

Altratech raises EUR 10.5 million in EIC Accelerator Programme funding

Funding

  • Altratech has secured EUR 10.5 million (~USD 11.5 million) from the European Innovation Council’s (EIC) Accelerator Programme.

  • The company intends to channel these funds toward running clinical trials on HIV patients, scaling up manufacturing capabilities, and advancing product development efforts over the next three years. The company is also receiving ongoing support from Enterprise Ireland (EI) for developing its platform and conducting trials. 

  • Altratech is a biotechnology company focused on developing innovative viral detection technologies, aiming to create a methodology or product that can detect any virus in a non-clinical setting without using an enzymatic step. Altratech's technology combines chemistry, biology, microfluidics, and silicon chip design to study viral detection outside of traditional settings.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.